Buffered NAD+
Buffered NAD+, supplied as lyophilized powder in a sealed vial.
- Form
- Lyophilized powder
- Contents
- 1 vial, 500 mg
Tested before it ships
Measured
551.20 mg
Label: 500 mg
- Lot
- MZN-NAD50009102026-20
- Endotoxin
- Below 10 EU per vial (9.30 EU/vial estimate) September 21, 2026
- Heavy metals
- Arsenic, cadmium, lead, and mercury not detected September 18, 2026
- Lab
- Janoshik Analytical
- Tested
- September 22, 2026
- Shipping
- Delivery options and costs are shown at checkout.
- Returns
- No returns. Lost or damaged in transit? See the returns policy.
Specifications
| Strength | 500 mg |
|---|---|
| Form | Lyophilized powder |
| Molecular formula | C21H27N7O14P2 |
| Molecular weight | 663.4 g/mol |
| CAS number | 53-84-9 |
| PubChem | View on PubChem |
| Storage | Store at −20 °C, protected from light. |
Description
NAD+ is nicotinamide adenine dinucleotide in its oxidized form, a coenzyme rather than a peptide. Its nicotinamide nucleotide and adenine nucleotide are joined by a pyrophosphate bridge. Supplied as buffered lyophilized powder in a single sealed vial.